¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇѾϿÏÈ­¡¤ÁöÁöÀǷῬ±¸È¸ Çмú´ëȸ ¹× Á¤±âÃÑȸ : 2024-03-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇѾϿÏÈ­¡¤ÁöÁöÀǷῬ±¸È¸ Çмú´ëȸ ¹× Á¤±âÃÑȸ : 2024-03-23
±³À°ÀÏÀÚ : 2024-03-23
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿¡ºñ½¼ÀÇ»ý¸í¿¬±¸¼¾ÅÍ 1Ãþ À¯ÀÏÇÑȦ

±³À°ÁÖÁ¦ : 2024 ´ëÇѾϿÏÈ­¡¤ÁöÁöÀǷῬ±¸È¸ Çмú´ëȸ ¹× Á¤±âÃÑȸ

ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾϿÏÈ­ÁöÁöÀǷῬ±¸È¸

´ã´çÀÚ : ±è¹ÎÈñ
¿¬¶ôó : 02-735-2859

À̸ÞÀÏ : kascc@ksmo.or.kr

±³À°Á¾·ù : ³»°ú, ÀÇ·áÁ¤Ã¥

Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 70,000¿ø  

ºñ°í »çÀüµî·Ïºñ(2024³â 2¿ù 23ÀϱîÁö)40,000¿ø ±³¼ö/Àü¹®ÀÇ/¹Ú»ç±Þ ¿¬±¸¿ø20,000¿ø ÀüÀÓÀÇ/Àü°øÀÇ/¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø ¹× Çлý/°£È£»ç/°øº¸ÀÇ/±ºÀÇ°ü 60,000¿ø ¾÷ü ¹× ±âŸÇöÀåµî·Ïºñ(2024³â 2¿ù 24ÀϺÎÅÍ)50,000¿ø ±³¼ö/Àü¹®ÀÇ/¹Ú»ç±Þ ¿¬±¸¿ø30,000¿ø ÀüÀÓÀÇ/Àü°øÀÇ/¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø ¹× Çлý/°£È£»ç/°øº¸ÀÇ/±ºÀÇ°ü 70,000¿ø ¾÷ü ¹× ±âŸ


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 09:30~01:00 Registration ()

±âŸ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 09:30~09:35 Opening Remarks °­Á¤ÈÆ(KASCC ȸÀå)

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 09:35~10:05 Challenges in supportive and palliative care research °­Á¤ÈÆ(°æ»ó´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú)

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 10:05~10:35 Grant landscape: Funding opportunities in supportive and palliative care research ÀåÀ±Á¤(±¹¸³¾Ï¼¾ÅÍ ±¹°¡¾Ï°ü¸®»ç¾÷º»ºÎ)

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 10:35~11:05 Questionnaire development and validation for survey research ÀÌÀºÇö(¾ÆÁÖ´ëÇб³ º¸°Ç´ëÇпø)

ÈÞ½Ä 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 11:05~11:15 Coffee Break ()

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 11:15~11:40 Risk assessment & prevention of Neutropenia following chemotherapy : Real world data of Eflapegrastim ±èÈñÁØ(Áß¾Ó´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú)

½Ä»ç 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 11:40~13:00 Á¡½É½Ä»ç ()

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 13:00~13:15 (Ç×¾ÏÁ¦¸¦ Á¦¿ÜÇÑ ¾à¹°ÀÇ) Çã°¡ÃÊ°ú ¾àÁ¦ »ç¿ë½ÂÀο¡ °üÇÑ ±âÁØ ¹× ÀýÂ÷ °­¹Ì¿µ(°Ç°­º¸Çè½É»çÆò°¡¿ø ¾àÁ¦°ü¸®½Ç ¾àÁ¦±âÁغÎ)

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 13:15~13:30 (Ç×¾ÏÁ¦¸¦ Á¦¿ÜÇÑ ¾à¹°ÀÇ) Çã°¡ÃÊ°ú ¾àÁ¦ »ç¿ë ½ÂÀÎ »ç·Ê ¼Ò°³ : ¿Ã¶õÀÚÇÉ »ç·Ê ¼Õº´¼®(ÀÎÁ¦´ëÇб³ »ó°è¹éº´¿ø Ç÷¾×Á¾¾ç³»°ú)

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 13:30~13:45 (Ç×¾ÏÁ¦¸¦ Á¦¿ÜÇÑ ¾à¹°ÀÇ) Çã°¡ÃÊ°ú ¾àÁ¦ »ç¿ëÀÌ ÇÊ¿äÇÑ ¾àÁ¦µé ÀÓÁÖÇÑ(ÀÎÇÏ´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú)

Åä·Ð 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 13:45~14:05 Panel discussion All()

ÈÞ½Ä 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 14:05~14:15 Coffee Break ()

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 14:15~14:25 Introduction of KCSG and palliative care committee Seok Jae Huh(Hemato-Oncology, Dong-A University, Korea)

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 14:25~14:45 Current status and barriers in supportive and palliative care research in Korea Se-Il Go(Hematology-Oncology, Gyeongsang National University Hospital, Korea)

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 14:45~15:05 Current status and barriers in supportive and palliative care research in Japan Tateaki Naito(Thoracic Oncology, Shizuoka Cancer Center, Japan)

±³À°½Ã°£ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 15:05~15:25 The role of pharmacists in research in the field of supportive care in cancer Yohei Iimura(Pharmacy, University of Tokyo, Japan)

Åä·Ð 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 15:25~15:45 Panel discussion: How to build a research collaboration All()

±âŸ 03¿ù 23ÀÏ À¯ÀÏÇÑȦ 15:45~16:00 2024 KASCC ÃÑȸ ¿ø¿µ¿õ(KASCC Ãѹ«À§¿øÀå)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇѾϿÏÈ­¡¤ÁöÁöÀǷῬ±¸È¸ Çмú´ëȸ ¹× Á¤±âÃÑȸ : 2024-03-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°úÀÇ ÃÖ½ÅÁö°ß 2024 : 2024-03-23
´ÙÀ½±Û (¿Â¶óÀÎ)´ëÇÑ¿µ»óÀÇÇÐȸ ¿¬¼ö±³À°(±âº»ÀûÀÎ ÀϹÝÃÔ¿µÀÇ ÀÌÇØ ¹× Æǵ¶) : 2024-03-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
810 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ½ÉÈ­±³À°(»çÀüµî·Ï Çʼö) : 2018-10-10 0 764 2018-09-06
809 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2018-10-06 0 1,379 2018-09-06
808 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦1ȸ ´ëÇѳú½Å°æ°è¹ßÀÛÁúȯ¿¬±¸È¸ Çмú´ëȸ (´ëÇѳúÀüÁõÇÐȸ °øµ¿°³ÃÖ) : 2018-10-06 0 1,776 2018-09-06
807 ¼­¿ï ´ëÇÑÅëÁõÀÚÀ²½Å°æÇÐȸ 2018³â Ãß°èÇмú´ëȸ : 2018-10-06 0 1,224 2018-09-06
806 ¼­¿ï ´ëÇÑÅëÁõÀÚÀ²½Å°æÇÐȸ Ãß°è¿öÅ©¼ó : 2018-10-06 0 546 2018-09-06
805 °æ±â ¼øõÇâ´ëÇб³ºÎõº´¿ø ½Å°æÇغÎÇа­Á : 2018-10-06 0 551 2018-09-06
804 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦1ȸ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ TB/NTM ±¹Á¦ ½ÉÆ÷Áö¾ö : 2018-10-05 0 632 2018-09-06
803 Ãæ³² ´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦139Â÷ ÃæûÁöȸ Áý´ãȸ : 2018-10-05 0 1,458 2018-09-06
802 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-10-04 0 320 2018-09-06
801 ´ë±¸ 2018³â ´ëÇÑ°ñ´ë»çÇÐȸ ´ë±¸.°æºÏÁöȸ Á¦4Â÷ °ñ´Ù°øÁõ ¿¬¼ö°­Á : 2018-09-30 0 1,688 2018-09-06
800 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ 2018³â ´ëÇÑÀ¯¹æ¿Ü°ú¿¬±¸È¸ Ãß°èÇмú´ëȸ : 2018-09-30 0 783 2018-09-06
799 ¼­¿ï ½ÅÃ̼¼ºê¶õ½ºº´¿ø Á¦ 10Â÷ ±Ù°ñ°Ý°è Áø´Ü ¹× Ä¡·á ¿¬¼ö°­Á : 2018-09-30 0 1,871 2018-09-06
798 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦58Â÷ ´ëÇÑÇÙÀÇÇÐȸ ÇÙÀÇÇп¬¼ö±³À° : 2018-09-29 0 551 2018-09-06
797 ¼­¿ï ¿ï»ê´ëÇб³º´¿ø Á¦ 57Â÷ Çѱ¹ÃéÀå¿Ü°ú¿¬±¸È¸ : 2018-09-29 0 751 2018-09-06
796 °æ±â Á¦45ȸ ´ëÇÑ°©»ó¼±µÎ°æºÎ¿Ü°úÇÐȸ Áõ·ÊÇмú´ëȸ : 2018-09-29 0 379 2018-09-06
1351 | 1352 | 1353 | 1354 | 1355 | 1356 | 1357 | 1358 | 1359 | 1360
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷